|
|
|
|
|
1
|
Lixte Biotechnology Holdings, Inc. (LIXT) - Strategic Analysis Review |
Aug 2010 |
$125.00 |
|
Lixte Biotechnology Holdings, Inc. (Lixte) is a research based cancer therapeutics and diagnostics company engaged in development of improved treatments of human cancers. The company is currently developing new chemotherapy drugs by targeting molecular abnormalities
more...
Published by: GlobalData
|
|
|
2
|
InNexus Biotechnology Inc. (IXS) - Strategic Analysis Review |
Sep 2010 |
$125.00 |
|
InNexus Biotechnology Inc. (InNexus) is a development stage biotechnology company focused on the development of the next generation of monoclonal antibodies using its Dynamic Cross-linking (DXL) technology. The DXL technology seeks to improve the therapeutic
more...
Published by: GlobalData
|
|
|
3
|
Cytos Biotechnology AG (CYTN) - Financial and Strategic Analysis Review |
Aug 2010 |
$125.00 |
|
Cytos Biotechnology AG (Cytos Biotechnology) is a biotechnology company, engaged in the discovery, development and commercialization of a novel class of biopharmaceutical products called Immunodrugs, used in the treatment and prevention of common chronic diseases
more...
Published by: GlobalData
|
|
|
4
|
The Dynamic Media, Sera and Reagent Market in Biotechnology |
Jul 2010 |
$4,850.00 |
|
THIS REPORT CONTAINS
Total worldwide sales revenues for media, sera, and reagent used in the biotechnology were $2,546.2million in 2010, and are expected to increase to more than $3800 Million in 2015,
more...
Published by: BCC Research
| Search inside this report |
|
|
5
|
Financial Health of the Biotechnology Industry |
Jul 2010 |
$6,000.00 |
|
The research services examines the financial performance of biotechnology companies across 2 broad parameters- Excellence in financial management and Excellence in risk management. The companies are analysed using over 50 financial ratios and other parameters
more...
Published by: Frost & Sullivan
|
|
|
6
|
Biotechnology in the US - Industry Risk Rating Report |
Jul 2010 |
$825.00 |
|
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Biotechnology in the US industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business
more...
Published by: IBISWorld
| Search inside this report |
|
|
7
|
Biotechnologies for Medical Applications: Global Markets |
May 2010 |
$4,850.00 |
|
THIS REPORT CONTAINS
An overview of biotechnologies used in medical applications, including amino acids, monoclonals, stem cells, botanicals, vaccines, recombinant DNA, and nanobiotechnology
Analysis of market trends, with data for
more...
Published by: BCC Research
|
|
|
8
|
Future of Red Biotechnology in China |
Apr 2010 |
$10,150.00 |
|
Red biotechnology (RB) refers to the biotechnology applied in pharmaceutical production and it has become the most important part in biotechnology industry. About 60% of achievements in biotechnology in the world are applied in production
more...
Published by: CCM International Limited
|
|
|
9
|
United States Biotechnology Industry - Porter’s Five Forces Strategy Analysis |
May 2010 |
$175.00 |
|
The rapidly emerging biotechnology industry is a critical element of national power. Advances in biotechnology are resulting in novel biomedical and pharmaceutical products and processes that are relieving human suffering, improving health, and increasing the
more...
Published by: Aruvian's R'search
| Search inside this report |
|
|
10
|
Commonwealth Biotechnologies, Inc. - Financial and Strategic Analysis Review |
Dec 2009 |
$125.00 |
|
Commonwealth Biotechnologies, Inc. - Financial and Strategic Analysis Review Summary Global Markets Direct’s “Commonwealth Biotechnologies, Inc. - Financial and Strategic Analysis Review” is an in-depth business, strategic and financial analysis of Commonwealth Biotechnologies, Inc. The report provides
more...
Published by: Global Markets Direct
|
|
|
11
|
Cougar Biotechnology, Inc. - Financial and Strategic Analysis Review |
Dec 2009 |
$125.00 |
|
Cougar Biotechnology, Inc. - Financial and Strategic Analysis Review Summary Global Markets Direct’s “Cougar Biotechnology, Inc. - Financial and Strategic Analysis Review” is an in-depth business, strategic and financial analysis of Cougar Biotechnology, Inc. The report provides
more...
Published by: Global Markets Direct
|
|
|
12
|
Apex Biotechnology Corp. Market Share Analysis |
Nov 2009 |
$1,000.00 |
|
Apex Biotechnology Corp. Market Share Analysis Summary This report is an essential source for data, analysis and strategic insight into the medical equipment business of Apex Biotechnology Corp. The report provides key information relating to Apex Biotechnology
more...
Published by: GlobalData
| Search inside this report |
|
|
13
|
Generex Biotechnology Corporation - Financial and Strategic Analysis Review |
Dec 2009 |
$125.00 |
|
Generex Biotechnology Corporation - Financial and Strategic Analysis Review Summary Global Markets Direct’s “Generex Biotechnology Corporation - Financial and Strategic Analysis Review” is an in-depth business, strategic and financial analysis of Generex Biotechnology Corporation The report provides
more...
Published by: Global Markets Direct
|
|
|
14
|
Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline |
Feb 2010 |
$3,500.00 |
|
Summary
GBI Research, the leading business intelligence provider, has released its latest research, “Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline”, which provides an insight into
more...
Published by: GBI Research
|
|
|
15
|
Future of Green Biotechnology in China |
Oct 2009 |
$6,650.00 |
|
This report is the unique and latest one available in the world to provide good understanding about Green Biotechnology (GB) in China and to find out business opportunities in this field. The first edition of
more...
Published by: CCM International Limited
|
|
|
16
|
CAMLOG Biotechnologies AG Market Share Analysis |
Nov 2009 |
$1,000.00 |
|
CAMLOG Biotechnologies AG Market Share Analysis Summary This report is an essential source for data, analysis and strategic insight into the medical equipment business of CAMLOG Biotechnologies AG. The report provides key information relating to CAMLOG Biotechnologies
more...
Published by: GlobalData
| Search inside this report |
|
|
17
|
The Global Market for Equipment Used in Biotechnology Applications |
Jan 2010 |
$4,850.00 |
|
THIS REPORT:
Provide forecasts for the global market, with data for 2007 and 2008, estimates for 2009, and projections for the market and compound annual growth rates (CAGRs) from 2009 to 2014
more...
Published by: BCC Research
|
|
|
18
|
Small and Medium Biopharmaceutical Enterprises in North America and Europe - Biotechnology Clusters, Funding Characteristics and Regulatory Landscape |
Feb 2010 |
$3,500.00 |
|
Small and Medium Biopharmaceutical Enterprises in North America and Europe - Biotechnology Clusters, Funding Characteristics and Regulatory Landscape Summary GBI Research, the leading business intelligence provider, has released its latest research, “Small and Medium Biopharmaceutical Enterprises in
more...
Published by: GBI Research
|
|
|
19
|
The BioWorld® Biotechnology State of the Industry Report 2009 |
Dec 2009 |
$599.00 |
|
The ultimate industry report measuring the progress of business, science and regulation in biotechnology.
"This comprehensive status report on the biotechnology industry, published by BioWorld Today, is a required reference for
more...
Published by: Bioworld Online/AHC Media
|
|
|
20
|
United States Biotechnology Industry - Porter’s Five Forces Strategy Analysis |
Nov 2009 |
$175.00 |
|
The rapidly emerging biotechnology industry is a critical element of national power. Advances in biotechnology are resulting in novel biomedical and pharmaceutical products and processes that are relieving human suffering, improving health, and increasing the
more...
Published by: Aruvian's R'search
| Search inside this report |
|
|
21
|
Champions Biotechnology, Inc.-Therapeutic Competitors |
Jan 2010 |
$350.00 |
|
Champions Biotechnology, Inc.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and stage of development, and competitors by therapeutic
more...
Published by: Life Science Analytics (LSA)
| Search inside this report |
|
|
22
|
Generex Biotechnology Corporation-Therapeutic Competitors |
Jan 2010 |
$350.00 |
|
Generex Biotechnology Corporation-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and stage of development, and competitors by therapeutic
more...
Published by: Life Science Analytics (LSA)
| Search inside this report |
|
|
23
|
Lixte Biotechnology Holdings, Inc.-Therapeutic Competitors |
Jan 2010 |
$350.00 |
|
Lixte Biotechnology Holdings, Inc.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and stage of development, and competitors by
more...
Published by: Life Science Analytics (LSA)
| Search inside this report |
|
|
24
|
2009 Chemicals, Pharmaceuticals, Medical Products & Biotechnology- Uk Key Corporate Changes |
Jan 2010 |
$299.00 |
|
1.1 Executive Summary
The Mandis 2009 Key Corporate Changes report for the UK Chemicals, Pharmaceuticals, Medical Products & Biotechnology Sector will put you ahead of your competition in terms of market knowledge. This
more...
Published by: Quantum Consulting Group, PLC
| Search inside this report |
|
|
25
|
Biotechnology Reagents |
Oct 2008 |
$3,950.00 |
|
This report analyzes the worldwide markets for Biotechnology Reagents in Millions of US$. The specific product segments analyzed are Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents,
more...
Published by: Global Industry Analysts
|
|
|
|
|
|
0 items
